Drug Profile
Research programme: neural stem cell mediated cancer therapy - GenVec/TheraBiologics
Alternative Names: NSC-mediated cancer therapy - GenVec/TheraBiologicsLatest Information Update: 28 Oct 2019
Price :
$50
*
At a glance
- Originator GenVec; TheraBiologics
- Class Gene therapies; Stem cell therapies
- Mechanism of Action Cell replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer